Analysts at Oppenheimer downgraded Morgan Stanley (NYSE: MS) to “Market Perform” from “Outperform” today, following its Q2 earnings release yesterday.
This downgrade comes despite the stock trading above Oppenheimer’s target price of $102, fueled by a robust Q2 performance that surpassed Wall Street expectations.
Q2 earnings
In Q2 2024, Morgan Stanley reported a robust set of financials with a GAAP EPS of $1.82, surpassing the $1.65 consensus and marking an increase from $1.24 in Q2 2023.
This earnings beat was driven by a notable rebound in trading revenue and solid performance in investment banking, reflecting a broader recovery in capital markets.
Despite the favorable results, the provision for credit losses rose to $76 million, exceeding forecasts and highlighting potential risk areas amidst financial successes.
Q2 revenue for Morgan Stanley was equally impressive, with net revenue reaching $15.0 billion, an 11.1% year-over-year increase.
This growth was balanced across its three primary segments: Institutional Securities, Wealth Management, and Investment Management.
The Institutional Securities segment remained flat quarter-over-quarter but saw a significant 23% increase year-over-year. Investment banking revenue jumped 51% compared to the previous year, driven by heightened activity in equity underwriting and fixed income.
Wealth Management revenue, accounting for a substantial portion of the overall revenue, slightly dipped by 1% from the previous quarter but improved by 2% year-over-year.
This segment’s resilience is underpinned by Morgan Stanley’s vast client assets, which have grown to $5.69 trillion, showcasing robust asset inflows despite a volatile market.
The Investment Management division also showed strength, with revenues rising by 8% year-over-year, primarily fueled by higher asset management revenues as long-term average assets under management increased.
Shareholder return and valuation
Amid these financial updates, Morgan Stanley also announced strategic capital maneuvers, including an 8.8% increase in its quarterly dividend to $0.925 per share and the reauthorization of a $20 billion stock repurchase program.
These shareholder-friendly actions not only reflect the firm’s solid financial health but also its confidence in sustaining capital adequacy and profitability.
However, despite these strong fundamentals analysts from Oppenheimer express caution.
They highlight that while Morgan Stanley is well-positioned in several areas, competitors like Goldman Sachs and Jefferies might be better placed to capitalize on the ongoing market recovery.
Valuation-wise, Morgan Stanley appears to be hovering near its fair value, given its current trading levels. This suggests that the stock might not offer substantial upside potential in the near term, aligning with Oppenheimer’s downgrade rationale.
Furthermore, with the stock trading near its all-time highs, the room for significant price appreciation may be limited unless the firm can deliver exceptional growth or efficiency improvements beyond market expectations.
In the broader context, Morgan Stanley’s strategic initiatives, such as its increased focus on wealth and investment management, have positioned it well for a less cyclical, more stable revenue stream.
The firm’s pursuit of a substantial increase in client assets and improvements in operational efficiency testify to its strategic direction aimed at long-term sustainability and growth.
Now, let’s see what the charts have to say about the stock’s price trajectory, transitioning into a technical analysis to further dissect the investment prospects of Morgan Stanley in light of its strengths and market challenges.
Bullish above $100
Following its all-time high of $109.73 made in February 2022, Morgan Stanley’s stock retraced and was trading in a $70-$100 range for more than two years. It made a decisive breakout above this range earlier this month.
Though the stock will remain in an uptrend as long as it trades above $100, investors bullish on the stock must initiate fresh long positions only if it gives a daily closing above the previous all-time high at $109.73 as that will signal the start of a fresh bull run.
Traders who are bearish on the stock must wait for it to close below $100 or the 50-day moving average to initiate short positions.
If that happens, they can go short with a stop loss of $111. If bears gain control, the stock can fall back to its recent swing low near $85.6 where profits can be booked.
The post Oppenheimer downgrades Morgan Stanley post Q2: Sell or Hold? appeared first on Invezz
